Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (11292)
All Articles published online
|
Publishing Process of This Article
|
Sep 21, 2016 (publication date) through Oct 31, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Fusco N, Bosari S. HER2 aberrations and heterogeneity in cancers of the digestive system: Implications for pathologists and gastroenterologists. World J Gastroenterol 2016; 22(35): 7926-7937 [PMID: 27672288 DOI: 10.3748/wjg.v22.i35.7926] |
|---|---|
| URL: | https://www.wjgnet.com/2218-4333/full/v22/i35/7926.htm |
| Number | Citing Articles |
| 1 |
Hong-Da Pan, Yi-Fan Peng, Gang Xiao, Jin Gu. High levels of serum platelet-derived growth factor-AA and human epidermal growth factor receptor-2 are predictors of colorectal cancer liver metastasis. World Journal of Gastroenterology 2017; 23(7): 1233-1240 doi: 10.3748/wjg.v23.i7.1233
|
| 2 |
Csongor G. Lengyel, Baker Habeeb, Shah Z. Khan, Khalid El Bairi, Sara C. Altuna, Sadaqat Hussain, Syed Ayub Mazher, Dario Trapani, Angelica Petrillo. Role of Her-2 in Gastrointestinal Tumours beyond Gastric Cancer: A Tool for Precision Medicine. Gastrointestinal Disorders 2020; 3(1): 1 doi: 10.3390/gidisord3010001
|
| 3 |
Masakazu Fujimoto, Ibu Matsuzaki, Masaru Nishino, Yoshifumi Iwahashi, Kenji Warigaya, Fumiyoshi Kojima, Kazuo Ono, Shin-Ichi Murata. HER2 is frequently overexpressed in hepatoid adenocarcinoma and gastric carcinoma with enteroblastic differentiation: a comparison of 35 cases to 334 gastric carcinomas of other histological types. Journal of Clinical Pathology 2018; 71(7): 600 doi: 10.1136/jclinpath-2017-204928
|
| 4 |
Yujing Xuan, Yuqiao Sheng, Daiqun Zhang, Kai Zhang, Zhen Zhang, Yu Ping, Shumin Wang, Xiaojuan Shi, Jingyao Lian, Kangdong Liu, Yi Zhang, Feng Li. Targeting CD276 by CAR-T cells induces regression of esophagus squamous cell carcinoma in xenograft mouse models. Translational Oncology 2021; 14(8): 101138 doi: 10.1016/j.tranon.2021.101138
|
| 5 |
Madison Sherman, Karolina Gaebe, Alyssa Y. Li, Steven Habbous, Arjun Sahgal, Michael J. Raphael, Anders W. Erickson, Sunit Das. Erythroblastic oncogene B-2 status and intracranial metastatic disease in patients with gastrointestinal cancer: a systematic review. Journal of Neuro-Oncology 2022; 160(3): 735 doi: 10.1007/s11060-022-04195-1
|
| 6 |
Samuel Navarro, Miriam Cuatrecasas, Javier Hernández-Losa, Stefania Landolfi, Eva Musulén, Santiago Ramón y Cajal, Rocío García-Carbonero, Jesús García-Foncillas, Pedro Pérez-Segura, Ramón Salazar, Ruth Vera, Pilar García-Alfonso. Actualización de la recomendación para la determinación de biomarcadores en el carcinoma colorrectal. Consenso Nacional de la Sociedad Española de Oncología Médica y de la Sociedad Española de Anatomía Patológica. Revista Española de Patología 2021; 54(1): 41 doi: 10.1016/j.patol.2020.07.004
|
| 7 |
Gianluca Lopez, Francesca Boggio, Stefano Ferrero, Nicola Fusco, Alessandro Del Gobbo. Molecular and Immunohistochemical Markers with Prognostic and Predictive Significance in Liver Metastases from Colorectal Carcinoma. International Journal of Molecular Sciences 2018; 19(10): 3014 doi: 10.3390/ijms19103014
|
| 8 |
Cindy Neuzillet, Pascal Artru, Eric Assenat, Julien Edeline, Xavier Adhoute, Jean-Christophe Sabourin, Anthony Turpin, Romain Coriat, David Malka. Optimizing Patient Pathways in Advanced Biliary Tract Cancers: Recent Advances and a French Perspective. Targeted Oncology 2023; 18(1): 51 doi: 10.1007/s11523-022-00942-6
|
| 9 |
Haowen Tang, Wenping Lu, Bingmin Li, Chonghui Li, Yinzhe Xu, Jiahong Dong. Prognostic significance of neutrophil-to-lymphocyte ratio in biliary tract cancers: a systematic review and meta-analysis. Oncotarget 2017; 8(22): 36857 doi: 10.18632/oncotarget.16143
|
| 10 |
Mariia Ivanova, Francesca Maria Porta, Marianna D’Ercole, Carlo Pescia, Elham Sajjadi, Giulia Cursano, Elisa De Camilli, Oriana Pala, Giovanni Mazzarol, Konstantinos Venetis, Elena Guerini-Rocco, Giuseppe Curigliano, Giuseppe Viale, Nicola Fusco. Standardized pathology report for HER2 testing in compliance with 2023 ASCO/CAP updates and 2023 ESMO consensus statements on HER2-low breast cancer. Virchows Archiv 2024; 484(1): 3 doi: 10.1007/s00428-023-03656-w
|
| 11 |
Jean-Christophe Currie, Michel Demeule, Cyndia Charfi, Alain Zgheib, Alain Larocque, Bogdan Alexandru Danalache, Amira Ouanouki, Richard Béliveau, Christian Marsolais, Borhane Annabi. The Peptide-Drug Conjugate TH1902: A New Sortilin Receptor-Mediated Cancer Therapeutic against Ovarian and Endometrial Cancers. Cancers 2022; 14(8): 1877 doi: 10.3390/cancers14081877
|
| 12 |
Shijie Sheng, M. Margarida Bernardo, Sijana H. Dzinic, Kang Chen, Elisabeth I. Heath, Wael A. Sakr. Tackling tumor heterogeneity and phenotypic plasticity in cancer precision medicine: our experience and a literature review. Cancer and Metastasis Reviews 2018; 37(4): 655 doi: 10.1007/s10555-018-9767-4
|
| 13 |
Mariia Ivanova, Konstantinos Venetis, Elena Guerini-Rocco, Luca Bottiglieri, Mauro Giuseppe Mastropasqua, Ornella Garrone, Nicola Fusco, Michele Ghidini. HER2 in Metastatic Colorectal Cancer: Pathology, Somatic Alterations, and Perspectives for Novel Therapeutic Schemes. Life 2022; 12(9): 1403 doi: 10.3390/life12091403
|
| 14 |
Mariia Ivanova, Elham Sajjadi, Lorenzo Zattoni, Nicola Fusco. Hereditary Gastric and Breast Cancer Syndrome. 2023; : 149 doi: 10.1007/978-3-031-21317-5_10
|
| 15 |
Anna D. Wagner, Berna C. Özdemir, Josef Rüschoff. Human epidermal growth factor receptor 2-positive digestive tumors. Current Opinion in Oncology 2019; 31(4): 354 doi: 10.1097/CCO.0000000000000544
|
| 16 |
Gianluca Lopez, Jole Costanza, Matteo Colleoni, Laura Fontana, Stefano Ferrero, Monica Miozzo, Nicola Fusco. Molecular Insights into the Classification of Luminal Breast Cancers: The Genomic Heterogeneity of Progesterone-Negative Tumors. International Journal of Molecular Sciences 2019; 20(3): 510 doi: 10.3390/ijms20030510
|
| 17 |
Gianluca Lopez, Konstantinos Venetis, Elham Sajjadi, Nicola Fusco. Mismatch Repair System Genomic Scars in Gastroesophageal Cancers: Biology and Clinical Testing. Gastrointestinal Disorders 2020; 2(4): 341 doi: 10.3390/gidisord2040031
|
| 18 |
Fabio Pagni, Elena Guerini-Rocco, Anne Maria Schultheis, Giulia Grazia, Erika Rijavec, Michele Ghidini, Gianluca Lopez, Konstantinos Venetis, Giorgio Alberto Croci, Umberto Malapelle, Nicola Fusco. Targeting Immune-Related Biological Processes in Solid Tumors: We do Need Biomarkers. International Journal of Molecular Sciences 2019; 20(21): 5452 doi: 10.3390/ijms20215452
|
| 19 |
S.T. Kim, K.C. Banks, E. Pectasides, S.Y. Kim, K. Kim, R.B. Lanman, A. Talasaz, J. An, M.G. Choi, J.H. Lee, T.S. Sohn, J.M. Bae, S. Kim, S.H. Park, J.O. Park, Y.S. Park, H.Y. Lim, N.K.D. Kim, W. Park, H. Lee, A.J. Bass, K. Kim, W.K. Kang, J. Lee. Impact of genomic alterations on lapatinib treatment outcome and cell-free genomic landscape during HER2 therapy in HER2+ gastric cancer patients. Annals of Oncology 2018; 29(4): 1037 doi: 10.1093/annonc/mdy034
|
| 20 |
Antonio Ieni, Roberta Cardia, Cristina Pizzimenti, Pio Zeppa, Giovanni Tuccari. HER2 Heterogeneity in Personalized Therapy of Gastro-Oesophageal Malignancies: An Overview by Different Methodologies. Journal of Personalized Medicine 2020; 10(1): 10 doi: 10.3390/jpm10010010
|
| 21 |
P. García-Alfonso, R. García-Carbonero, J. García-Foncillas, P. Pérez-Segura, R. Salazar, R. Vera, S. Ramón y Cajal, J. Hernández-Losa, S. Landolfi, E. Musulén, M. Cuatrecasas, S. Navarro. Update of the recommendations for the determination of biomarkers in colorectal carcinoma: National Consensus of the Spanish Society of Medical Oncology and the Spanish Society of Pathology. Clinical and Translational Oncology 2020; 22(11): 1976 doi: 10.1007/s12094-020-02357-z
|
| 22 |
Maria Diab, Asfar Azmi, Ramzi Mohammad, Philip A. Philip. Pharmacotherapeutic strategies for treating pancreatic cancer: advances and challenges. Expert Opinion on Pharmacotherapy 2019; 20(5): 535 doi: 10.1080/14656566.2018.1561869
|
| 23 |
Massimiliano Salati, Konstantinos Venetis, Matteo Fassan, Umberto Malapelle, Fabio Pagni, Elham Sajjadi, Nicola Fusco, Michele Ghidini. ctDNA Analysis in the Personalized Clinical Management of Gastroesophageal Adenocarcinoma: Turning Hope Into Reality. Future Oncology 2021; 17(33): 4607 doi: 10.2217/fon-2021-0228
|
| 24 |
Konstantinos Venetis, Marco Invernizzi, Elham Sajjadi, Giuseppe Curigliano, Nicola Fusco. Cellular immunotherapy in breast cancer: The quest for consistent biomarkers. Cancer Treatment Reviews 2020; 90: 102089 doi: 10.1016/j.ctrv.2020.102089
|
| 25 |
Elsa N. Garza Treviño, Adriana G. Quiroz Reyes, Juan Antonio Rojas Murillo, David A de la Garza Kalife, Paulina Delgado Gonzalez, Jose F. Islas, Ana Esther Estrada Rodriguez, Carlos A. Gonzalez Villarreal. Cell Therapy as Target Therapy against Colon Cancer Stem Cells. International Journal of Molecular Sciences 2023; 24(9): 8163 doi: 10.3390/ijms24098163
|
| 26 |
Keita Kai, Yukie Yoda, Atsushi Kawaguchi, Akimichi Minesaki, Hironori Iwasaki, Shinichi Aishima, Hirokazu Noshiro. Formalin fixation on HER-2 and PD-L1 expression in gastric cancer: A pilot analysis using the same surgical specimens with different fixation times. World Journal of Clinical Cases 2019; 7(4): 419-430 doi: 10.12998/wjcc.v7.i4.419
|
| 27 |
Li-Fei Sun, Kun Yang, Yi-Gao Wang, Yu-Xin Liu, Pei-Xian Hou, Zheng-Hao Lu, Xiao-Long Chen, Wei-Han Zhang, Zong-Guang Zhou, Xian-Ming Mo, Jian-Kun Hu. The Role of HER2 in Self-Renewal, Invasion, and Tumorigenicity of Gastric Cancer Stem Cells. Frontiers in Oncology 2020; 10 doi: 10.3389/fonc.2020.01608
|
| 28 |
Pragya Jain, Surbhi Goyal, Geeta Chauhan, Kaushik Majumdar, Shahajad Ali, Puja Sakhuja, AnilK Agarwal. HER-2/neu over expression in gall bladder adenocarcinoma: A quest for potential therapeutic target. Indian Journal of Pathology and Microbiology 2020; 63(2): 214 doi: 10.4103/IJPM.IJPM_664_19
|
| 29 |
Ayumi Saito, Hiroshi Yoshida, Tadaaki Nishikawa, Kan Yonemori. Human epidermal growth factor receptor 2 targeted therapy in endometrial cancer: Clinical and pathological perspectives. World Journal of Clinical Oncology 2021; 12(10): 868-881 doi: 10.5306/wjco.v12.i10.868
|
| 30 |
Ioan Cătălin Bodea, Andra Ciocan, Florin Vasile Zaharie, Raluca Bodea, Florin Graur, Ștefan Ursu, Răzvan Alexandru Ciocan, Nadim Al Hajjar. HER2 Overexpression in Periampullary Tumors According to Anatomical and Histological Classification—A Systematic Review. Journal of Personalized Medicine 2024; 14(5): 463 doi: 10.3390/jpm14050463
|
| 31 |
Dustin E. Bosch, Matthew M. Yeh, Paul E. Swanson. Gattuso's Differential Diagnosis in Surgical Pathology. 2022; : 405 doi: 10.1016/B978-0-323-66165-2.00007-7
|
| 32 |
Marco Invernizzi, Anna Michelotti, Marianna Noale, Gianluca Lopez, Letterio Runza, Massimo Giroda, Luca Despini, Concetta Blundo, Stefania Maggi, Donatella Gambini, Nicola Fusco. Breast Cancer Systemic Treatments and Upper Limb Lymphedema: A Risk-Assessment Platform Encompassing Tumor-Specific Pathological Features Reveals the Potential Role of Trastuzumab. Journal of Clinical Medicine 2019; 8(2): 138 doi: 10.3390/jcm8020138
|
| 33 |
Lulu Rong, Bingzhi Wang, Lei Guo, Xiuyun Liu, Bingning Wang, Jianming Ying, Liyan Xue, Ning Lu. HER2 expression and relevant clinicopathological features in esophageal squamous cell carcinoma in a Chinese population. Diagnostic Pathology 2020; 15(1) doi: 10.1186/s13000-020-00950-y
|
| 34 |
Davinder Singh, Divya Dheer, Abhilash Samykutty, Ravi Shankar. Antibody drug conjugates in gastrointestinal cancer: From lab to clinical development. Journal of Controlled Release 2021; 340: 1 doi: 10.1016/j.jconrel.2021.10.006
|
| 35 |
Hayley Pye, Mohammed Adil Butt, Laura Funnell, Halla W. Reinert, Ignazio Puccio, Saif U. Rehman Khan, Savvas Saouros, Jared S. Marklew, Ioanna Stamati, Maryam Qurashi, Rehan Haidry, Vinay Sehgal, Dahmane Oukrif, Michael Gandy, Hayley C. Whitaker, Manuel Rodriguez-Justo, Marco Novelli, Rifat Hamoudi, Gokhan Yahioglu, Mahendra P. Deonarain, Laurence B. Lovat. Using antibody directed phototherapy to target oesophageal adenocarcinoma with heterogeneous HER2 expression. Oncotarget 2018; 9(33): 22945 doi: 10.18632/oncotarget.25159
|
| 36 |
Konstantinos Venetis, Edoardo Crimini, Elham Sajjadi, Chiara Corti, Elena Guerini-Rocco, Giuseppe Viale, Giuseppe Curigliano, Carmen Criscitiello, Nicola Fusco. HER2 Low, Ultra-low, and Novel Complementary Biomarkers: Expanding the Spectrum of HER2 Positivity in Breast Cancer. Frontiers in Molecular Biosciences 2022; 9 doi: 10.3389/fmolb.2022.834651
|
| 37 |
Aaditya Srivant Geddam, Areeb Lutfi, Maaz Khan Afghan, Brian M. Currie, Russell Rosenblatt, Arturo B. Ramirez, Erin G. Bayer, Erika Hissong, Pashtoon Murtaza Kasi. Liquid biopsy kinetics and detection of ERBB2 amplification/HER2-positivity in refractory hepatocellular carcinoma. The Journal of Liquid Biopsy 2023; 2: 100009 doi: 10.1016/j.jlb.2023.100009
|
| 38 |
Chiara Pedicone, Shea T. Meyer, John D. Chisholm, William G. Kerr. Targeting SHIP1 and SHIP2 in Cancer. Cancers 2021; 13(4): 890 doi: 10.3390/cancers13040890
|
| 39 |
Han-Qi Wang, Ruxing Fu, Qi-Wen Man, Guang Yang, Bing Liu, Lin-Lin Bu. Advances in CAR-T Cell Therapy in Head and Neck Squamous Cell Carcinoma. Journal of Clinical Medicine 2023; 12(6): 2173 doi: 10.3390/jcm12062173
|